3305 PD1 inhibition-induced changes in melanoma and its associated immune infiltrate

Ricardo E. Vilain; Hojabr Kakavand; Alexander M. Menzies; Jason Madore; James S. Wilmott; R. Dobney; Valerie Jakrot; Andrea Cooper; Ben L. Kong; Serigne Lo; Elizabeth Liniker; R.P.M. Saw; Jill Thompson; Richard Kefford; Matteo S. Carlino; Georgina V. Long; Richard A Scolyer

doi:10.1016/s0959-8049(15)30063-0

Related publications

Editorial Material2015

Immune infiltrate in cancer

Gautier Stoll, Laurence Zitvogel, Guido Guido Kroemer

Article2019

Clinicopathologic characteristics of immune colitis in melanoma patients treated with combination ipilimumab and anti-PD1 (IPI+PD1) and PD1 monotherapy

Kazi Nahar, Robert V. Rawson, N S Sandanayake, Stephen Tattersal, Matteo S. Carlino, Umaimainthan Palendira, Richard A Scolyer, Georgina V. Long, Alexander M. Menzies

Article2016

Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate

Sylvain Ladoire, Laura Senovilla, David Enot, François Ghiringhelli, Vichnou Poirier-Colame, Kariman Chaba, Gulsun Erdag, Jochen T. Schaefer, Donna H. Deacon, Laurence Zitvogel, Craig L. Slingluff, Guido Guido Kroemer

Article2025

Distinct effect of neoadjuvant PD1 alone, PD1+IPI, and PD1+lenvatinib in the peripheral immune profile of melanoma patients (pts) and correlation with pathological (path) response.

Inês Pires da Silva, Jordan W. Conway, Akshaya Ramanathan, Laura Smith, Nurudeen A. Adegoke, Jorja Braden, Maria Gonzalez, Richard A Scolyer, Umaimainthan Palendira, Matteo S. Carlino, Christian U. Blank, Alexander M. Menzies, Georgina V. Long

Article2020

The tumour immune landscape and its implications in cutaneous melanoma

Grace H. Attrill, Peter M. Ferguson, Umaimainthan Palendira, Georgina V. Long, James S. Wilmott, Richard A Scolyer